Proactive Quality Orchestration: Agentic, Evidence-Grounded Release Decisioning
A unified agentic model that investigates, detects, and scopes quality events in real time, delivering continuous monitoring and defensible release calls at every step.
The Cost of Static Quality System in an Always-On Industry
Pharma manufacturing is scaling across more sites, more markets, and more regulatory jurisdictions every year, and quality now has to move at the same pace. Annual product quality reviews were built for a slower, single-site era — designed to confirm a problem after the fact, not catch the signal the moment it appears.
Across multi-site manufacturing networks, closing a major deviation can stretch to 6–12 months industry-wide, and that gap only widens as production footprints grow, leaving less and less room for a purely retrospective, once-a-cycle review.
45–75 days
per major deviation, start to finish
8–10
2–4x
From Reactive Quality Control to Continuous Release Reasoning
Saama provides an Agent OS-orchestrated Quality Intelligence solution for pharma manufacturing. By connecting historical precedent, real-time monitoring, and full batch-to-market traceability into one system, we transform fragmented quality data into evidence-grounded release decisions that move as fast as production does.
Three Pillars Behind Every Decision
From retrieval-grounded investigation to cross-system impact scoping — a seamless agentic journey.
Retrieval-Grounded Investigation
Drafts investigation narratives cited to source records, grounded in evidence at every step.
Continuous Signal & CAPA Monitoring
Systematically scans closed deviations and CAPAs for recurring themes and precursor signals.
Cross-System Impact Traversal
Traverses batch genealogy across Vault, MES, and ERP to find every impacted batch or market.
A Complete, End-to-End Quality Intelligence Suite
Six agentic use cases, governed by one shared context framework.
Deviation Investigation
Retrieval-grounded root-cause drafting and CAPA recommendation from a manufacturer’s own investigation history.
Complaint Reportability Triage
Confidence-scored regulatory reportability determination with citation to source criteria.
Audit Readiness / Inspection Response
Cross-framework compliance gap analysis and predictive inspection-risk scoring.
Change Control Impact Assessment
Cross-system impact traversal for proposed process or specification changes.
Batch Release Risk Scoring
Predictive release-risk scoring to prioritize quality review attention.
Training Effectiveness (CAPA)
Correlates training-as-CAPA against actual recurrence-rate outcomes.
The Case for Running Quality Decisions Our Agentic Way
Where the approach earns its keep, review over review, release over release.
40–50%
Cuts the major-deviation timeline against today’s 45–75 day baseline.
70%
Pre-screens every eBR entry, so reviewers focus only on the exceptions that actually need attention.
2–4x → ~1x
Compressed QA Cycles
Fewer passes before signature tightens each record’s path to approval.
+20–30%
QA Capacity Redeployed
Budget curves evolve continuously as data flows in, allowing allocation decisions to draw on real-time evidence rather than static quarterly or annual refreshes.
Engineered to Outperform the Status Quo
See how Saama Agentic Quality Intelligence redefines the standards of traditional QMS tools.
Preemptive Risk Sensing
Systemic patterns surface well before annual review, catching what would otherwise wait until it’s too late.
Reduced Recall Exposure
Faster cross-system scoping limits the fallout to only what’s actually affected, keeping corrective action targeted.
Deterministic by Design
Every correction is rule-governed and regulatory-grade, grounded in predictable, repeatable logic.
Full Genealogy Visibility
Every batch and market link stays traceable end to end, so nothing slips through and product reaches patients sooner.
A Leaner Path to Quality
Smarter investigation and less rework compound into a measurably lower-cost operation over time.
Zero Infrastructure Disruption
Starts on standard eBR and MES exports, so your existing QMS and ERP systems remain fully intact.
Ready to move from scheduled quality checks to real-time release confidence?
The next era of pharma quality belongs to teams who act on signals the moment they appear, draw on their own historical precedent, and stand behind every release with a record they can defend.
